A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents

Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor. Acquired factor V inhibitor represents a rare conditio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical case reports 2021-02, Vol.9 (2), p.623-628
Hauptverfasser:	Giuffrida, Gaetano, Markovic, Uros, Nicolosi, Daniela, Calafiore, Valeria
Format:	Artikel
Sprache:	eng
Schlagworte:	acquired coagulation inhibitor Anemia Antibiotics Anticoagulants Asymptomatic Autoimmune diseases Biomarkers Blood platelets Blood tests bypassing agents Cardiac arrhythmia Case Report Case Reports dabigatran factor V Hematoma Hematuria immunosuppressive therapy Laboratories Peptides Steroids Stroke
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor. Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.3586